Cargando…

A Prognostic Model of Triple-Negative Breast Cancer Based on miR-27b-3p and Node Status

OBJECTIVE: Triple-negative breast cancer (TNBC) is an aggressive but heterogeneous subtype of breast cancer. This study aimed to identify and validate a prognostic signature for TNBC patients to improve prognostic capability and to guide individualized treatment. METHODS: We retrospectively analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Songjie, Sun, Qiang, Liang, Zhiyong, Cui, Xiaojiang, Ren, Xinyu, Chen, Huan, Zhang, Xiao, Zhou, Yidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063964/ https://www.ncbi.nlm.nih.gov/pubmed/24945253 http://dx.doi.org/10.1371/journal.pone.0100664

Ejemplares similares

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
por: Xu, Qianqian, et al.
Publicado: (2016)

MiR-27a Modulates Radiosensitivity of Triple-Negative Breast Cancer (TNBC) Cells by Targeting CDC27
por: Ren, Yong-qiang, et al.
Publicado: (2015)

lncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression
por: Zhang, Xiaohui, et al.
Publicado: (2020)

Cancer-derived exosomal miR-7641 promotes breast cancer progression and metastasis
por: Shen, Songjie, et al.
Publicado: (2021)

Long noncoding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple-negative breast cancer
por: Zhang, Xiaohui, et al.
Publicado: (2021)

miR-452 Reverses Abnormal Glycosylation Modification of ERα and Estrogen Resistance in TNBC (Triple-Negative Breast Cancer) Through Targeting UGT1A1
por: Li, Yan, et al.
Publicado: (2020)

Insulin-like growth factor 2 receptor is a key immune-related gene that is correlated with a poor prognosis in patients with triple-negative breast cancer: A bioinformatics analysis
por: Zhong, Ying, et al.
Publicado: (2022)

Syndecan-1 as an immunogene in Triple-negative breast cancer: regulation tumor-infiltrating lymphocyte in the tumor microenviroment and EMT by TGFb1/Smad pathway
por: Zhong, Ying, et al.
Publicado: (2023)

Prognostic value of various immune cells and Immunoscore in triple-negative breast cancer
por: Ren, Xinyu, et al.
Publicado: (2023)

miR-205 and miR-200c: Predictive Micro RNAs for Lymph Node Metastasis in Triple Negative Breast Cancer
por: Berber, Ufuk, et al.
Publicado: (2014)

Prognostic significance of different molecular typing methods and immune status based on RNA sequencing in HR-positive and HER2-negative early-stage breast cancer
por: Ren, Xinyu, et al.
Publicado: (2022)

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
por: Rhee, Jiyoung, et al.
Publicado: (2008)

VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer
por: Cao, Xi, et al.
Publicado: (2021)

The lymph node ratio as an independent prognostic factor for node-positive triple-negative breast cancer
por: He, Min, et al.
Publicado: (2017)

Predictors of nonsentinel lymph node metastasis in patients with breast cancer with metastasis in the sentinel node
por: Zhou, Yidong, et al.
Publicado: (2019)

Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis
por: Wang, Changjun, et al.
Publicado: (2016)

MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival
por: Tang, Wei, et al.
Publicado: (2012)

Down Regulated Expression Levels of miR-27b and miR-451a as a Potential Biomarker for Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy
por: Abdul Aziz, Ahmad Aizat, et al.
Publicado: (2022)

Lymph node status in different molecular subtype of breast cancer: triple negative tumours are more likely lymph node negative
por: Liu, Ning, et al.
Publicado: (2017)

A Prognostic Model for Triple-Negative Breast Cancer Patients Based on Node Status, Cathepsin-D and Ki-67 Index
por: Huang, Liang, et al.
Publicado: (2013)

MiR-27a-3p Targeting GSK3β Promotes Triple-Negative Breast Cancer Proliferation and Migration Through Wnt/β-Catenin Pathway
por: Wu, Ruizhen, et al.
Publicado: (2020)

MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer
por: Xu, Xin, et al.
Publicado: (2016)

Significance of miR-27a and miR-31 in early diagnosis and prognosis of colorectal cancer
por: Cui, Qingjun
Publicado: (2019)

Prognostic significance of branched-chain amino acid transferase 1 and CD133 in triple-negative breast cancer
por: Song, Yu, et al.
Publicado: (2020)

Increased expression of miR-155 and miR-222 is associated with lymph node positive status
por: Chernyy, Vladimir, et al.
Publicado: (2018)

Nomogram for Predicting Lymph Node Involvement in Triple-Negative Breast Cancer
por: Cui, Xiang, et al.
Publicado: (2020)

miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells
por: Salah, Zaidoun, et al.
Publicado: (2015)

Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2015)

Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates
por: Bertoli, Gloria, et al.
Publicado: (2021)

The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer
por: Zhang, Lei, et al.
Publicado: (2020)

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
por: Fkih M’hamed, Insaf, et al.
Publicado: (2015)

Evaluation of NTRK Gene Fusion by Five Different Platforms in Triple-Negative Breast Carcinoma
por: Wu, Shafei, et al.
Publicado: (2021)

Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less
por: Kwon, Ji Hyun, et al.
Publicado: (2010)

Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2016)

Mammographic casting-type calcification is an independent prognostic factor in invasive breast cancer
por: Li, Yan, et al.
Publicado: (2019)

miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells
por: Nassirpour, Rounak, et al.
Publicado: (2013)

MiR-940 Inhibited Cell Growth and Migration in Triple-Negative Breast Cancer
por: Hou, Lingmi, et al.
Publicado: (2016)

Therapeutic Potential of Chemically Modified miR-489 in Triple-Negative Breast Cancers
por: Soung, Young Hwa, et al.
Publicado: (2020)

The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer
por: Shang, Yulong, et al.
Publicado: (2015)

Identification of Potential Key Genes Associated With the Pathogenesis, Metastasis, and Prognosis of Triple-Negative Breast Cancer on the Basis of Integrated Bioinformatics Analysis
por: Zhao, Bin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hht8nnjqe5ron45pbg3qersvan